NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Cisplatin-Ineligible Patients With Locally Advanced HNSCC: A Phase I Trial

• DOI: 10.1016/j.ijrobp.2020.07.267
• Publication Date: 2020-10-23T23:01:11Z
• Authors: C. Le Tourneau; V. Calugaru; E. Borcoman; V. Moreno; E. Calvo; X. Liem; S. Salas; B. Doger; O. Choussy; M. Lesnik; X. Mirabel; N. Badois; S. [e-mail]; J. Blomkvist; N. Fakhry; S. Wong Hee Kam; C. Hoffmann
• Keywords: 03 medical and health sciences; 0302 clinical medicine